Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 10, 2022
Source ID
10.1021/acs.jmedchem.2c00046

Entities

People

  • Andrea Escobar-peña
  • Debora Zian
  • Giovanni Cincilla
  • Henar Vázquez-Villa
  • Jerold Chun
  • Manisha Ray
  • Maria Puigdomenech-poch
  • María L López-Rodríguez
  • Melchor Sanchez-Martinez
  • Nora Khiar-fernández
  • R. Fernando Martínez
  • Román Foronda-sainz
  • Ruben Lopez-vales
  • Silvia Ortega-Gutiérrez
  • Yasuyuki Kihara

Organizations

  • Autonomous University of Barcelona
  • Catalan Institution for Research and Advanced Studies
  • Complutense University of Madrid
  • National Institute of Mental Health
  • National Institute of Neurological Disorders and Stroke
  • Sanford Burnham Prebys Medical Discovery Institute
  • United States Department of Defense